This meta-analysis conducted a more comprehensive analysis of the relationship between three IL-10 polymorphisms (rs1800896, rs1800871, and rs1800872) and BC risk by including 23 studies (published between 2004 and 2019) and ruling out the researches with low quality. The gene discussed is IL10; the disease is breast cancer.